Connect with us

Hi, what are you looking for?

Investing

Stocks to Watch: Apellis Pharmaceuticals

Published

By Sabela Ojea



Apellis Pharmaceuticals on Tuesday provided an update on the eye-disease drug Syfovre, which has been dogged by safety concerns in recent weeks. Shares of the biopharmaceutical company surged 31%, to $40.35, in after-hours trading.




Write to Sabela Ojea at [email protected]




Read the full article here

			

	

		

			

				In this article:
			

						

							

						

				
				
			

																	

						 Click to comment
					

					

				
	
	

		
Leave a Reply
 
Your email address will not be published. Required fields are marked *
 
 



 


 


 


	

	

									

	


						

													

								
							

											

				

			

																		 	

 		
 	

 									

			

		

			

				

					

						You May Also Like
					

				

									

													

			

			

				
												
			

			

	

					
Videos

				

			
			
Ray Dalio to donate $75M to Trump accounts. 💰

			
		

		
Watch full video on YouTube

		

			2 days ago
		

	


		

	
													

			

			

				
												
			

			

	

					
Videos

				

			
			
Bessent: “Any concern on Director Hassett is absurd.”

			
		

		
Watch full video on YouTube

		

			3 days ago
		

	


		

	
													

			

			

				
												
			

			

	

					
Videos

				

			
			
How Boeing Turned Things Around After Years Of Decline

			
		

		
Watch full video on YouTube

		

			2 days ago
		

	


		

	
													

			

			

				
												
			

			

	

					
News

				

			
			
Brookfield: Transition Into An Insurance Play Continues (NYSE:BN)

			
		

		
This article was written by Follow The author has an honours degree in economics and politics with a focus on economic development. With 36...

		

			3 days ago